3[5]Biesma DH, van den Tweel JG,verdonc KLF,Immunosuppresive therapy for hypoplastic myelodysplastic syndrome[J].Cancer ,1997,79:1548-1551.
4[6]Jonasova A ,Neuwistava R,Gera KJ,et al.cyclosporin A theraphy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow[J].Br J haematol,1998,100:304-309.
5[7]Luraschi A,saglietti G,Fedeli P,et al.Immunological indices in myelodysplastic syndrome[J].Minerva Medica,1994,85:145-153.
6[8]Pavlova IE,Abdulkadyrov KM,The characteristics of the lymphoid population in myelodysplasitc states[J].Gematol Transfuziol,1993,38:22-26.
7[10]shetty V,Mandle S,Alvo S,et al.Measurment of apoptosis,proliferation and three cytokines in 46 patients with myelodysplasitc syndrome[J].leu.Res,1996,20(11/12):891.
8姚尔固,主编.新编白血病化疗学.第1版.天津:科学技术出版社,1998.203
9Shetty V,Mandle S,Alvo S,et al.Measurment of apoptosis,proliferation and three cytokines in 46 patients with myelodysplasitc syndrome.leu.Res,1996,20(11/12):891
